Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling face, Vaccination site erythema
Clinical narrative: chills; arm pain; stated that she has a line with TMJ on the right side of her jaw; headaches or migraines that got worse after taking the dose; swelling of her right jaw; rash on her cheek; a red mark on the site where she was injected; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64-year-old female patient received BNT162b2 (BNT162B2), on 08Apr2022 as dose 4 (booster), 0.3 ml single (Lot number: EX9895) at the age of 64 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Stated that she had cancer four times last year right above her lip" (unspecified if ongoing), notes: Stated that she had cancer four times last year right above her lip., Stated that the doctor had to open her up a second and third time. Stated that after the fourth time it was cleared in the margins and everywhere. Stated that this was in Aug or Sep 2021; "econd cancer on her lip was on 29 Jun 2021.", start date: 29Jun2021 (unspecified if ongoing), notes: second cancer on her lip was on 29Jun2021; "breast cancer", start date: 2002 (unspecified if ongoing), notes: Breast cancer Started in 2001 or 2002., Stated that she has lymphedema from breast cancer in her left arm since age 42.; "Lymphedema" (unspecified if ongoing), notes: Stated that she has lymphedema from breast cancer in her left arm since age 42.; "migraines" (unspecified if ongoing), notes: she had migraines before the vaccine; "Surgery" (unspecified if ongoing), notes: Stated that she had four surgeries for basal cell on the lip last year. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1), administration date: 23Sep2021, when the patient was 63-year-old, for Covid-19 immunization; BNT162b2 (Dose: 3), administration date: 16Aug2021, when the patient was 63-year-old, for COVID-19 immunization; Bnt162b2 (Dose: 2), for Covid-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 08Apr2022, outcome "not recovered", described as "a red mark on the site where she was injected"; CONDITION AGGRAVATED (non-serious) with onset 08Apr2022, outcome "not recovered", described as "headaches or migraines that got worse after taking the dose"; RASH (non-serious) with onset 08Apr2022, outcome "recovering", described as "rash on her cheek"; SWELLING FACE (non-serious) with onset 08Apr2022, outcome "recovering", described as "swelling of her right jaw"; CHILLS (non-serious), outcome "unknown"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm pain"; FACE INJURY (non-serious), outcome "not recovered", described as "stated that she has a line with TMJ on the right side of her jaw". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information- It was reported that experienced swelling of her right jaw, rash on her cheek, and a red mark on the site where she was injected. Caller also added later on that she also experienced chills, arm pain, and headaches or migraines that got worse after taking the dose. No follow-up attempts are needed. No further information is expected